Resultaten

Artikel
Dit item is dichtgeklapt
Dit item is opengeklapt

Titel: Predictive models diagnosing in indolent cancer
Auteur(s): Bangma CH, Roobol MJ, Steyerberg EW
Tijdschrift: Cancer
Start- en eindpagina: 3100 - 3106

Titel: Anxiety and distress during active surveillance for early prostate cancer
Auteur(s): van den Bergh RC, Essink-Bot ML, Roobol MJ, Wolters T, Schröder FH, Bangma CH, Steyerberg EW
Tijdschrift: Cancer
Start- en eindpagina: 3868 - 3878

Titel: Prostate cancer mortality reduction by prostate-specific antigen-based screening adjusted for nonattendance and contamination in the European Randomised study of Screening for Prostate Cancer (ERSPC)
Auteur(s): Roobol MJ, Kerkhof M, Schröder FH, Cuzick J, Sasieni P, Hakama M, Stenman UH, Ciatto S, Nelen V, Kwiatkowski M, Lujan M, Lilja H, Zappa M, Denis L, Recker F, Berenguer A, Ruutu M, Kujala P, Bangma CH, Aus G, Tammela TL, Villers A, Rebillard X, Moss SM, de Koning HJ, Hugosson J, Auvinen A
Tijdschrift: European Urology
Start- en eindpagina: 584 - 591

Titel: A framework for the identification of men at increased risk for prostate cancer
Auteur(s): Roobol MJ, Schröder FH, Crawford D, Freedland SJ, Sartor O, Fleshner N, Andriole GL
Tijdschrift: Journal of Urology
Start- en eindpagina: 2112 - 2122

Titel: The effect of study arm on prostate cancer treatment in the large screening trial ERSPC
Auteur(s): Wolters T, Roobol MJ, Steyerberg EW, van den Bergh RCN, Bangma CH, Hugosson J, Ciatto S, Kwiatkowski M, Villers A, Lujan M, Nelen V, Tammela TLJ, Schröder FH
Tijdschrift: International Journal of Cancer
Start- en eindpagina: 79 - 85

Titel: Should pathologists routinely report prostate tumour volume? The prognostic value of tumour volume in prostate cancer
Auteur(s): Wolters T, Roobol MJ, van Leeuwen PJ, van den Bergh RCN, Hoedemaeker RF, van Leenders GJLH, Schröder FH, van der Kwast ThH
Tijdschrift: European Urology
Start- en eindpagina: 0 - 0

Titel: A risk-based strategy improves prostate-specific antigen-driven detection of prostate cancer
Auteur(s): Roobol MJ, Steyerberg EW, Kranse R, Wolters T, van den Bergh RCN, Bangma CH, Schröder FH
Tijdschrift: European Urology
Start- en eindpagina: 79 - 85

Titel: Eleven-year outcome of patients with prostate cancer diagnosed during screening after initial negative sextant biopsies
Auteur(s): Schröder FH, van den Bergh RCN, Wolters T, van Leeuwen PJ, Bangma CH, van der Kwast ThH, Roobol MJ
Tijdschrift: European Urology
Start- en eindpagina: 256 - 266

Titel: Overdetection, overtreatment and costs in prostate-specific antigen screening for prostate cancer
Auteur(s): Heijnsdijk EA, der Kinderen A, Wever EN, Draisma G, Roobol MJ, de Koning HJ
Tijdschrift: British Journal of Cancer
Start- en eindpagina: 1833 - 1838

Titel: Prostate cancer mortality in screen and clinically detected prostate cancer: estimating the screening benefit
Auteur(s): van Leeuwen PJ, Connolly D, Gavin A, Roobol MJ, Black A, Bangma CH, Schröder FH
Tijdschrift: European Journal of Cancer
Start- en eindpagina: 377 - 383

Titel: Short-term outcomes of the prospective multicentre ‘Prostate Cancer Research International: Active Surveillance’ study
Auteur(s): van den Bergh RCN, Vasarainen H, van der Poel HG, Vis-Maters JJ, Rietbergen JBW, Pickles T, Cornel EB, Valdagni R, Jaspars JJ, van der Hoeven J, Staerman F, Oomens EHGM, Rannikko A, Roemeling S, Steyerberg EW, Roobol MJ, Schröder FH, Bangma CH
Tijdschrift: British Journal of Urology International
Start- en eindpagina: 956 - 62

Titel: Informed decision making on PSA testing for the detection of prostate cancer: an evaluation of a leaflet with risk indicator
Auteur(s): van Vugt HA, Roobol MJ, Venderbos LD, Joosten-van Zwanenburg E, Essink-Bot ML, Steyerberg EW, Bangma CH, Korfage IJ
Tijdschrift: European Journal of Cancer
Start- en eindpagina: 669 - 677

Titel: Is delayed radical prostatectomy in men with low-risk screen-detected prostate cancer associated with a higher risk of unfavourable outcomes?
Auteur(s): van den Bergh RCN, Steyerberg EW, Khatami A, Aus G, Pihl CG, Wolters T, van Leeuwen PJ, Roobol MJ, Schröder FH, Hugosson J
Tijdschrift: Cancer
Start- en eindpagina: 1281 - 1290

Titel: PSA screening – a review of recent studies
Auteur(s): Schröder FH
Tijdschrift: European Journal of Cancer
Start- en eindpagina: 402 - 404

Titel: ERSPC and PLCO prostate cancer screening studies: what are the differences?
Auteur(s): Schröder FH, Roobol MJ
Tijdschrift: European Urology
Start- en eindpagina: 46 - 52

Titel: Overall survival in the intervention arm of a randomized controlled screening trial for prostate cancer compared with a clinically diagnosed cohort
Auteur(s): Vis AN, Roemeling S, Reedijk AJM, Otto SJ, Schröder FH
Tijdschrift: European Urology
Start- en eindpagina: 91 - 98

Titel: Early detection of prostate cancer in 2007. Part 1: PSA and PSA kinetics
Auteur(s): Schröder FH, Carter HB, Wolters T, van den Bergh RC, Gosselaar C, Bangma CH, Roobol MJ
Tijdschrift: European Urology
Start- en eindpagina: 468 - 477

Titel: Is it necessary to detect all prostate cancers in men with serum PSA levels <3.0 ng/ml? A comparison of biopsy results of PCPT and outcome-related information from ERSPC
Auteur(s): Schröder FH, Bangma CH, Roobol MJ
Tijdschrift: European Urology
Start- en eindpagina: 901 - 908

Titel: Screening for prostate cancer in Dutch hereditary prostate cancer families
Auteur(s): Kiemeny LA, Broeders MJ, Pelger M, Kil PJ, Schröder FH, Witjes JA, Vasen HF
Tijdschrift: International Journal of Cancer
Start- en eindpagina: 871 - 876

Titel: Words of wisdom: (I) Re: prostate specific antigen velocity in men with total prostate specific antigen less than 4 ng/ml
Auteur(s): Roobol MJ
Tijdschrift: European Urology
Start- en eindpagina: 852 - 854

Titel: Words of wisdom: (II) Re: prostate specific antigen velocity in men with total prostate specific antigen less than 4 ng/ml
Auteur(s): Roobol MJ
Tijdschrift: European Urology
Start- en eindpagina: 854 - 855

Titel: Algorithms, nomograms and the detection of indolent prostate cancer
Auteur(s): Roobol MJ
Tijdschrift: World Journal of Urology
Start- en eindpagina: 423 - 429

Titel: Is prostate-specific antigen velocity selective for clinically significant prostate cancer in screening? European Randomized Study of Screening for Prostate Cancer (Rotterdam)
Auteur(s): Wolters T, Roobol MJ, Bangma CH, Schröder FH
Tijdschrift: European Urology
Start- en eindpagina: 0 - 0

Titel: Reply from authors re: Martha K. Terris. Editorial comment on: is prostate-specific antigen velocity selective for clinically significant prostate cancer in screening? European Randomized Study of Screening for Prostate Cancer (Rotterdam)
Auteur(s): Wolters T, Schröder FH
Tijdschrift: European Urology
Start- en eindpagina: 0 - 0

Titel: Digital rectal examination and the diagnosis of prostate cancer - a study based on 8 years and three screenings within the European Randomized Study of Screening for Prostate Cancer (ERSPC), Rotterdam
Auteur(s): Gosselaar C, Roobol MJ, van den Bergh RC, Wolters T, Schröder FH
Tijdschrift: European Urology
Start- en eindpagina: 0 - 0

Titel: The role of the digital rectal examination in subsequent screening visits in the European Randomized Study of Screening for Prostate Cancer (ERSPC), Rotterdam
Auteur(s): Gosselaar C, Roobol MJ, Roemeling S, Schröder FH
Tijdschrift: European Urology
Start- en eindpagina: 581 - 588

Titel: The interobserver variability of digital rectal examination in a large randomized trial for the screening of prostate cancer
Auteur(s): Gosselaar C, Kranse R, Roobol MJ, Roemeling S, Schröder FH
Tijdschrift: Prostate
Start- en eindpagina: 985 - 993

Titel: Prostate-specific antigen kinetics in clinical decision-making during active surveillance for early prostate cancer - a review
Auteur(s): van den Bergh RCN, Roemeling S, Roobol MJ, Wolters T, Schröder FH, Bangma CH
Tijdschrift: European Urology
Start- en eindpagina: 505 - 516

Titel: Validation of pretreatment nomograms for predicting indolent prostate cancer: efficacy in contemporary urological practice
Auteur(s): Dong F, Kattan MW, Steyerberg EW, Jones JS, Stephenson AJ, Schröder FH, Klein EA
Tijdschrift: Journal of Urology
Start- en eindpagina: 150 - 154

Titel: Does 'normal' aging imply urinary, bowel and erectile dysfunction? A general population survey
Auteur(s): Korfage IJ, Roobol MJ, de Koning HJ, Kirkels WJ, Schröder FH, Essink-Bot ML
Tijdschrift: Urology
Start- en eindpagina: 3 - 9

Titel: Outcomes of men with screen-detected prostate cancer eligible for active surveillance who were managed expectantly
Auteur(s): van den Bergh RC, Roemeling S, Roobol MJ, Aus G, Hugosson J, Rannikko AS, Tammela TL, Bangma CH, Schröder FH
Tijdschrift: European Urology
Start- en eindpagina: 0 - 0

Titel: Reply from authors re: Peter C. Albertsen. The treatment paradigm shifts again on prostate cancer
Auteur(s): van den Bergh RC, Roemeling S, Roobol MJ, Aus G, Hugosson J, Rannikko AS, Tammela TL, Bangma CH, Schröder FH
Tijdschrift: European Urology
Start- en eindpagina: 0 - 0

Titel: Is there evidence of a relationship between benign prostatic hyperplasia and prostate cancer? Findings of a literature review
Auteur(s): Alcaraz A, Hammerer P, Tubaro A, Schröder FH, Castro R
Tijdschrift: European Urology
Start- en eindpagina: 0 - 0

Titel: A graphical device to represent the outcomes of a logistic regression analysis
Auteur(s): Kranse R, Roobol MJ, Schröder FH
Tijdschrift: Prostate
Start- en eindpagina: 1674 - 1680

Titel: Defining increased future risk for prostate cancer: evidence from a population based screening cohort
Auteur(s): Schröder FH, Roobol MJ, Andriole GL, Fleshner N
Tijdschrift: Journal of Urology
Start- en eindpagina: 0 - 0

Titel: Clinical impact of new prostate-specific antigen WHO standardization on biopsy rates and cancer detection
Auteur(s): Jansen FH, Roobol M, Bangma CH, van Schaik RH
Tijdschrift: Clinical Chemistry
Start- en eindpagina: 1999 - 2006

Titel: Defining increased future risk for prostate cancer: evidence from a population based screening cohort
Auteur(s): Schröder FH, Roobol MJ, Andriole GL, Fleshner N
Tijdschrift: Journal of Urology
Start- en eindpagina: 69 - 74

Titel: Erectile dysfunction and mental health in a general population of older men
Auteur(s): Korfage IJ, Pluijm S, Roobol M, Dohle GR, Schröder FH, Essink-Bot ML
Tijdschrift: The journal of sexual medicine
Start- en eindpagina: 505 - 512

Titel: Screening and prostate-cancer mortality in a randomized European study
Auteur(s): Schröder FH, Hugosson J, Roobol MJ, Tammela TLJ, Ciatto S, Nelen V, Kwiatkowski M, Lujan M, Lilja H, Zappa M, Denis LJ, Recker F, Berenguer A, Määttänen L, Bangma CH, Aus G, Villers A, Rebillard X, van der Kwast T, Blijenberg BG, Moss SM, de Koning HJ, Auvinen A, for the ERSPC Investigators
Tijdschrift: New England Journal of Medicine
Start- en eindpagina: 1320 - 1328

Titel: Mictie- en darmproblemen niet gerelateerd aan veroudering bij mannen, erectieproblemen wel
Auteur(s): Korfage IJ, Roobol MJ, de Koning HJ, Kirkels WJ, Schröder FH, Essink-Bot ML
Tijdschrift: Nederlands Tijdschrift voor Geneeskunde
Start- en eindpagina: 0 - 0

Titel: Prostate-specific antigen (PSA) alone is not an appropriate surrogate marker of long-term therapeutic benefit in prostate cancer trials. Eur J Cancer
Auteur(s): 370. Collette L, Burzykowski T, Schroder FH. Prostate-specific antigen (PSA) alone is not an appropriate surrogate marker of long-term therapeutic benefit in prostate cancer trials. Eur J Cancer. 2006 Jul;42(10):1344-50. Epub 2006 May 30. Review
Tijdschrift: European Journal of Cancer
Start- en eindpagina: 1344 - 1350

Titel: Tumor characteristics and prognostic factors in two subsequent screening rounds with four-year interval within prostate cancer screening trial, ERSPC Rotterdam.
Auteur(s): 483. van der Cruijsen-Koeter IW, Roobol MJ, Wildhagen MF, van der Kwast TH, Kirkels WJ, Schroder FH. Tumor characteristics and prognostic factors in two subsequent screening rounds with four-year interval within prostate cancer screening trial, ERSPC Rotterdam. Urology. 2006 Sep;68(3):615-20.
Tijdschrift: Urology
Start- en eindpagina: 615 - 620

Titel: Gleason score, age and screening: modeling dedifferentiation in prostate cancer
Auteur(s): Draisma G, Postma R, Schroder FH, van der Kwast TH, de Koning HJ. Gleason score, age and screening: modeling dedifferentiation in prostate cancer. Int J Cancer. 2006 Nov 15;119(10):2366-71.
Tijdschrift: International Journal of Cancer
Start- en eindpagina: 2366 - 2371

Titel: Screening for prostate cancer without digital rectal examination and transrectal ultrasound: results after 4 years in the European Randomized Study of Screening for Prostate cancer Rotterdam
Auteur(s): 486. Gosselaar C, Roobol MJ, Roemeling S, De Vries SH, Cruijsen-Koeter IJ, Van der Kwast TH, Schröder FH. Screening for prostate cancer without digital rectal examination and transrectal ultrasound: results after 4 years in the European Randomized Study of Screening for Prostate cancer Rotterdam. Prostate 2006;66(6):625-31.
Tijdschrift: Prostate
Start- en eindpagina: 625 - 631

Titel: Anxiety and depression after prostate cancer diagnosis and treatment: 5-year follow-up.
Auteur(s): 486. Korfage IJ, Essink-Bot ML, Janssens AC, Schroder FH, de Koning HJ. Anxiety and depression after prostate cancer diagnosis and treatment: 5-year follow-up. Br J Cancer. 2006 Apr 24;94(8):1093-8
Tijdschrift: British Journal of Cancer
Start- en eindpagina: 1093 - 1098

Titel: Detection rates of high-grade prostate cancer during subsequent screening visits. Results of the European Randomised Screening Study for Prostate Cancer
Auteur(s): Van der Kwast TH, Ciatto S, Martikainen PM, Hoedemaeker RF, Laurila M, Pihl CG, Hugosson J, Neetens I, Nelen V, Di Lollo S, Roobol MJ, Maatanen L, Santonja C, Moss S, Schröder FH. Detection rates of high-grade prostate cancer during subsequent screening visits. Results of the European Randomised Screening Study for Prostate Cancer. Int J Cancer 2006;118(10):2538-42.
Tijdschrift: International Journal of Cancer
Start- en eindpagina: 2538 - 2542

Titel: Risk of cardiovascular mortality in prostate cancer patients in the Rotterdam randomized screening trial. J
Auteur(s): Otto SJ, Schroder FH, de Koning HJ. Risk of cardiovascular mortality in prostate cancer patients in the Rotterdam randomized screening trial. J Clin Oncol. 2006 Sep 1;24(25):4184-9.
Tijdschrift: Journal of Clinical Oncology
Start- en eindpagina: 4184 - 4190

Titel: Tumour features in the control and screening arm of a randomized trial of prostate cancer.
Auteur(s): Postma R, van Leenders GJ, Roobol MJ, Schroder FH, van der Kwast TH. Tumour features in the control and screening arm of a randomized trial of prostate cancer. Euro Urol 2006;50(1):70-5.
Tijdschrift: European Urology
Start- en eindpagina: 70 - 75

Titel: Metastatic disease of screen-detected prostate cancer : characteristics at diagnosis
Auteur(s): Roemeling S, Kranse R, Vis AN, Gosselaar C, van der Kwast TH, Schroder FH. Metastatic disease of screen-detected prostate cancer : characteristics at diagnosis. Cancer. 2006 Dec 15;107(12):2779-85.
Tijdschrift: Cancer
Start- en eindpagina: 2779 - 2785

Titel: Management and survival of screen-detected prostate cancer patients who might have been suitable for active surveillance.
Auteur(s): Roemeling S, Roobol MJ, Postma R, Gosselaar C, van der Kwast TH, Bangma CH, Schroder FH. Management and survival of screen-detected prostate cancer patients who might have been suitable for active surveillance. Eur Urol. 2006 Sep;50(3):475-82.14:
Tijdschrift: European Urology
Start- en eindpagina: 475 - 482

Titel: Biochemical progression rates in the screen arm compared to the control arm of the Rotterdam Section of the European Randomized Study of Screening for Prostate Cancer (ERSPC).
Auteur(s): Roemeling S, Roobol MJ, Gosselaar C, Schroder FH. Biochemical progression rates in the screen arm compared to the control arm of the Rotterdam Section of the European Randomized Study of Screening for Prostate Cancer (ERSPC). Prostate. 2006 Jul 1;66(10):1076-81.
Tijdschrift: Prostate
Start- en eindpagina: 1076 - 1081

Titel: Prevalence, treatment modalities and prognosis of familial prostate cancer in a screened population
Auteur(s): Roemeling S, Roobol MJ, de Vries SH, Gosselaar C, van der Kwast TH, Schroder FH. Prevalence, treatment modalities and prognosis of familial prostate cancer in a screened population. J Urol. 2006 Apr;175(4):1332-6.
Tijdschrift: Journal of Urology
Start- en eindpagina: 1332 - 1336

Titel: Very late local recurrence after surgery for prostate cancer unaccompanied by detectable PSA levels.
Auteur(s): Roemeling S, van Leenders GJ, Schröder FH. Very late local recurrence after surgery for prostate cancer unaccompanied by detectable PSA levels. Prostate cancer Prostatic Dis 2006;9(2):192-4.
Tijdschrift: Prostate Cancer and Prostatic Disease
Start- en eindpagina: 192 - 194

Titel: Prostate Cancer: risks and benefits of screening
Auteur(s): Roemeling S, Schröder FH. Prostate Cancer: risks and benefits of screening. Nat Clin Pract Urol 2006;3(1):4-5
Tijdschrift: National Clinical Practice of Urology
Start- en eindpagina: 4 - 5

Titel: The use of nomograms in the detection of prostate cancer.
Auteur(s): Roobol MJ. The use of nomograms in the detection of prostate cancer. Prostate. 2006 Sep 1;66(12):1266-7
Tijdschrift: Prostate
Start- en eindpagina: 1266 - 1267

Titel: A comparison of first and repeat (4 years later) prostate cancer screening in a randomised cohort of a-symptomatic men aged 55-75 years using a biopsy indication of 3.0 ng/ml (results of ERSPC Rotterdam).
Auteur(s): Roobol MJ, Schröder FH, Kranse R. ERSPC Rotterdam. A comparison of first and repeat (4 years later) prostate cancer screening in a randomised cohort of a-symptomatic men aged 55-75 years using a biopsy indication of 3.0 ng/ml (results of ERSPC Rotterdam). Prostate 2006;66(6):604-12.
Tijdschrift: Prostate
Start- en eindpagina: 604 - 612

Titel: Early detection of prostate cancer. What do we tell our patients?
Auteur(s): Schroder FH, Erasmus MC. Early detection of prostate cancer. What do we tell our patients? Can J Urol. 2006 Apr;13 Suppl 2:37-42.
Tijdschrift: Canadian Journal of Urology
Start- en eindpagina: 37 - 42

Titel: The role of PSA in secondary screening of the same population
Auteur(s): Schroder FH. The role of PSA in secondary screening of the same population. Arch Ital Urol Androl. 2006 Dec;78(4):147-8.
Tijdschrift: Arch Ital Urol Androl
Start- en eindpagina: 147 - 148

Titel: Biomarkers and screening for prostate cancer
Auteur(s): Schroder FH. Biomarkers and screening for prostate cancer. Ann Oncol. 2006 Sep;17 Suppl 10:x201-x206.
Tijdschrift: Ann Oncol
Start- en eindpagina: 201 - 206

Titel: For the motion
Auteur(s): Schroder FH. For the motion. Eur Urol. 2006 Aug;50(2):377-9. .
Tijdschrift: European Urology
Start- en eindpagina: 377 - 379

Titel: Prostate specific antigen and other markers for prostate cancer
Auteur(s): Schroder FH. Prostate specific antigen and other markers for prostate cancer. J Urol. 2006 Apr;175(4):1199-200.
Tijdschrift: Journal of Urology
Start- en eindpagina: 1199 - 1200

Titel: Does PSA velocity predict prostate cancer in pre-screened populations?
Auteur(s): Schröder FH, Roobol MJ, Van der Kwast TH, Kranse R, Bangma CH. /Does PSA velocity predict prostate cancer in pre-screened populations?/ Eur Urol. 2006 Mar;49(3):460-5; discussion 465
Tijdschrift: European Urology
Start- en eindpagina: 460 - 465

Titel: Should We Replace the Gleason Score with the Amount of High-Grade Prostate Cancer?
Auteur(s): Vis AN, Roemeling S, Kranse R, Schroder FH, van der Kwast TH. Should We Replace the Gleason Score with the Amount of High-Grade Prostate Cancer? Eur Urol. 2007 Apr;51(4):931-9.
Tijdschrift: European Urology
Start- en eindpagina: 931 - 939

Titel: The actual value of the surgical margin status as a predictor of disease progression in men with early prostate cancer
Auteur(s): Vis AN, Schröder FH, van der Kwast TH. The actual value of the surgical margin status as a predictor of disease progression in men with early prostate cancer. Eur Urol 2006;50(2):258-65.
Tijdschrift: European Urology
Start- en eindpagina: 258 - 265

Titel: Overdiagnosis and overtreatment of early detected prostate cancer.
Auteur(s): Bangma CH, Roemeling S, Schroder FH. Overdiagnosis and overtreatment of early detected prostate cancer. World J Urol. 2007 Mar;25(1):3-9. Epub 2007 Feb 14.
Tijdschrift: World Journal of Urology
Start- en eindpagina: 3 - 9

Titel: Prediction of indolent prostate cancer: validation and updating of a prognostic nomogram.
Auteur(s): Steyerberg EW, Roobol MJ, Kattan MW, van der Kwast TH, de Koning HJ, Schroder FH. Prediction of indolent prostate cancer: validation and updating of a prognostic nomogram. J Urol. 2007 Jan;177(1):107-12; discussion 112.
Tijdschrift: Journal of Urology
Start- en eindpagina: 107 - 112

Titel: Screening for prostate cancer at low PSA range: the impact of digital rectal examination on tumor incidence and tumor characteristics.
Auteur(s): Gosselaar C, Roobol MJ, Roemeling S, van der Kwast TH, Schroder FH. Screening for prostate cancer at low PSA range: the impact of digital rectal examination on tumor incidence and tumor characteristics. Prostate. 2007 Feb 1;67(2):154-61
Tijdschrift: Prostate
Start- en eindpagina: 154 - 161

Titel: Overall and disease-specific survival of patients with screen-detected prostate cancer in the European randomized study of screening for prostate cancer, section Rotterdam.
Auteur(s): de Vries SH, Postma R, Raaijmakers R, Roemeling S, Otto S, de Koning HJ, Schroder FH. Overall and disease-specific survival of patients with screen-detected prostate cancer in the European randomized study of screening for prostate cancer, section Rotterdam. Eur Urol. 2007 Feb;51(2):366-74.
Tijdschrift: European Urology
Start- en eindpagina: 366 - 374

Titel: Prostate cancer in the Swedish section of ERSPC--evidence for less metastases at diagnosis but not for mortality reduction
Auteur(s): Schroder FH, Habbema DF, Roobol MJ, Bangma CH. Prostate cancer in the Swedish section of ERSPC--evidence for less metastases at diagnosis but not for mortality reduction. Eur Urol. 2007 Mar;51(3):588-90
Tijdschrift: European Urology
Start- en eindpagina: 588 - 590

Titel: Feasibility study of adjustment for contamination and non-compliance in a prostate cancer screening trial.
Auteur(s): Roemeling S, Roobol MJ, Otto SJ, Habbema DF, Gosselaar C, Lous JJ, Cuzick J, Schroder FH. Feasibility study of adjustment for contamination and non-compliance in a prostate cancer screening trial. Prostate. 2007 Jul 1;67(10):1053-60.
Tijdschrift: Prostate
Start- en eindpagina: 1053 - 1060

Titel: Early versus delayed endocrine therapy for prostate cancer
Auteur(s): Schroder FH. Early versus delayed endocrine therapy for prostate cancer. Endocr Relat Cancer. 2007 Mar;14(1):1-11.
Tijdschrift: Endocrine related Cancer
Start- en eindpagina: 1 - 11

Titel: Characteristics in the European Randomized Study of Screening for Prostate Cancer (ERSPC) - Section Rotterdam A Comparison of Two Rounds of Screening
Auteur(s): Postma R, Schroder FH, van Leenders GJ, Hoedemaeker RF, Vis AN, Roobol MJ, van der Kwast TH. Cancer Detection and Cancer Characteristics in the European Randomized Study of Screening for Prostate Cancer (ERSPC) - Section Rotterdam A Comparison of Two Rounds of Screening. Eur Urol. 2007 Jul;52(1):89-97.
Tijdschrift: European Urology
Start- en eindpagina: 89 - 97

Titel: Side-effects of treatment for localized prostate cancer: are they valued differently by patients and healthy controls?
Auteur(s): Korfage IJ, de Koning HJ, Habbema JD, Schroder FH, Essink-Bot ML. Side-effects of treatment for localized prostate cancer: are they valued differently by patients and healthy controls? BJU Int. 2007 Apr;99(4):801-6.
Tijdschrift: British Journal of Urology International
Start- en eindpagina: 801 - 806

Titel: Active surveillance for prostate cancers detected in three subsequent rounds of a screening trial: characteristics, PSA doubling times, and outcome
Auteur(s): Roemeling S, Roobol MJ, de Vries SH, Wolters T, Gosselaar C, van Leenders GJ, Schroder FH. Active surveillance for prostate cancers detected in three subsequent rounds of a screening trial: characteristics, PSA doubling times, and outcome. Eur Urol. 2007 May;51(5):1244-50
Tijdschrift: European Urology
Start- en eindpagina: 1244 - 1250

Titel: Bepaling van het indivudele risico op prostaatkanker en indolente tumoren
Auteur(s): Bangma C, Roobol-Bouts MJ, Schröder FH. /Bepaling van het indivudele risico op prostaatkanker en indolente tumoren./ Nederlands Tijdschrift voor Urologie, Nr. 5, September 2006: 148-151.
Tijdschrift: Nederlands Tijdschrift voor Urologie
Start- en eindpagina: 148 - 151

Titel: PSA and the detection of prostate cancer after 2005. //Part I/.
Auteur(s): Schröder FH, Gosselaar C, Roemeling S, Roemeling S, Postma R, Roobol MJ, Bangma CH. /PSA and the detection of prostate cancer after 2005. //Part I/. EAU-EBU Update Series 4 (2006) 2-12.
Tijdschrift: European Urology Update Series
Start- en eindpagina: 2 - 12

Proefschrift
Dit item is dichtgeklapt
Dit item is opengeklapt

Titel: Active surveillance for low risk prostate cancer
Auteur(s): van den Bergh RCN
Publicatiedatum: 09-12-2009

Titel: Improving screening strategies for prostate cancer
Auteur(s): Wolters T
Publicatiedatum: 28-04-2010

Titel: Population based screening for prostate cancer
Auteur(s): van der Cruijsen-Koëter IW
Publicatiedatum: 10-09-2008

Titel: Screening for prostate cancer. Digital rectal examination: outdated or still valuable?
Auteur(s): Gosselaar C
Publicatiedatum: 05-11-2008

Titel: Prostate Cancer Screening. The role of biopsy, PSA, PSA dynamics and isoforms
Auteur(s): Raaijmakers R
Publicatiedatum: 20-05-2009

Naar boven
Direct naar: InhoudDirect naar: NavigatieDirect naar: Onderkant website